Jacob F Kirkegaard, a senior fellow at the Peterson Institute for International Economics and German Marshall Fund, shared an article revealing how Russia’s vaccine geopolitics may fail its cause, as the country still relies upon imported vaccines for its Covid-19 inoculation programme.
Russia is exporting its domestic Sputnik V vaccine to needy countries, but the country itself is facing a slower rollout of vaccine at home and depends on cross-border trade to satisfy its vaccine supplies.
Russia is making up for the gap through overseas manufacturing and has made a few production deals with India and South Korea.
Russian President Vladimir Putin stated that a sufficient number of Sputnik V vaccine doses have been distributed to inoculate 8.9 million people across the country, since August 2020.
Vaccine imports are expected to ramp up in the coming weeks helping the country overcome its vaccination rollout, which is lagging behind its counterparts.
However, the role of imports in reducing the vaccine shortage in the country remains unclear, the article noted.